US Stock MarketDetailed Quotes

PYXS Pyxis Oncology

Watchlist
  • 3.920
  • +0.070+1.82%
Trading Jun 13 15:49 ET
230.84MMarket Cap-2861P/E (TTM)

Pyxis Oncology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
16.15M
0
0
0
0
0
0
0
0
0
Operating revenue
--16.15M
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
475K
0
Gross profit
15.67M
0
Operating expense
1.54%21.28M
-33.43%82.2M
-53.21%17.77M
-10.70%25.35M
-29.56%18.12M
-33.24%20.95M
77.12%123.48M
131.18%37.97M
144.32%28.39M
333.02%25.73M
Selling and administrative expenses
-8.90%8.25M
-12.70%32.61M
-24.13%6.16M
13.98%10.67M
-21.34%6.73M
-20.01%9.05M
100.14%37.35M
-11.75%8.12M
148.12%9.36M
212.72%8.56M
-General and administrative expense
-8.90%8.25M
-12.70%32.61M
-24.13%6.16M
13.98%10.67M
-21.34%6.73M
-20.01%9.05M
100.14%37.35M
-11.75%8.12M
148.12%9.36M
212.72%8.56M
Research and development costs
9.48%13.03M
-42.43%49.59M
-61.12%11.61M
-22.84%14.69M
-33.66%11.39M
-40.71%11.9M
68.70%86.13M
313.15%29.85M
142.50%19.03M
435.73%17.17M
Operating profit
73.25%-5.61M
33.43%-82.2M
53.21%-17.77M
10.70%-25.35M
29.56%-18.12M
33.24%-20.95M
-77.12%-123.48M
-131.18%-37.97M
-144.32%-28.39M
-333.02%-25.73M
Net non-operating interest income expense
-7.35%1.55M
139.87%6.63M
-14.85%1.59M
137.41%1.71M
909.76%1.66M
18,488.89%1.67M
11,917.39%2.76M
26,642.86%1.87M
11,883.33%719K
2,633.33%164K
Non-operating interest income
-7.35%1.55M
139.87%6.63M
-14.85%1.59M
137.41%1.71M
909.76%1.66M
18,488.89%1.67M
11,917.39%2.76M
26,642.86%1.87M
11,883.33%719K
2,633.33%164K
Other net income (expense)
2,002.63%799K
1.78M
576K
598K
564K
38K
Other non- operating income (expenses)
2,002.63%799K
--1.78M
--576K
--598K
--564K
--38K
----
----
----
----
Income before tax
83.08%-3.26M
38.87%-73.79M
56.80%-15.6M
16.71%-23.05M
37.79%-15.9M
38.68%-19.24M
-58.89%-120.72M
-114.52%-36.1M
-95.23%-27.67M
-213.80%-25.56M
Income tax
Net income
83.08%-3.26M
38.87%-73.79M
56.80%-15.6M
16.71%-23.05M
37.79%-15.9M
38.68%-19.24M
-58.89%-120.72M
-114.52%-36.1M
-95.23%-27.67M
-213.80%-25.56M
Net income continuous Operations
83.08%-3.26M
38.87%-73.79M
56.80%-15.6M
16.71%-23.05M
37.79%-15.9M
38.68%-19.24M
-58.89%-120.72M
-114.52%-36.1M
-95.23%-27.67M
-213.80%-25.56M
Minority interest income
Net income attributable to the parent company
83.08%-3.26M
38.87%-73.79M
56.80%-15.6M
16.71%-23.05M
37.79%-15.9M
38.68%-19.24M
-58.89%-120.72M
-114.52%-36.1M
-95.23%-27.67M
-213.80%-25.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
83.08%-3.26M
38.87%-73.79M
56.80%-15.6M
16.71%-23.05M
37.79%-15.9M
38.68%-19.24M
-58.89%-120.72M
-114.52%-36.1M
-95.23%-27.67M
-213.80%-25.56M
Basic earnings per share
88.89%-0.06
49.32%-1.85
68.27%-0.33
34.12%-0.56
48.10%-0.41
44.33%-0.54
59.22%-3.65
-99.13%-1.04
-90.29%-0.85
-207.76%-0.79
Diluted earnings per share
88.89%-0.06
49.32%-1.85
68.27%-0.33
34.12%-0.56
48.10%-0.41
44.33%-0.54
59.22%-3.65
-99.13%-1.04
-90.29%-0.85
-207.76%-0.79
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 16.15M000000000
Operating revenue --16.15M--0--0--0--0--0--0--0--0--0
Cost of revenue 475K0
Gross profit 15.67M0
Operating expense 1.54%21.28M-33.43%82.2M-53.21%17.77M-10.70%25.35M-29.56%18.12M-33.24%20.95M77.12%123.48M131.18%37.97M144.32%28.39M333.02%25.73M
Selling and administrative expenses -8.90%8.25M-12.70%32.61M-24.13%6.16M13.98%10.67M-21.34%6.73M-20.01%9.05M100.14%37.35M-11.75%8.12M148.12%9.36M212.72%8.56M
-General and administrative expense -8.90%8.25M-12.70%32.61M-24.13%6.16M13.98%10.67M-21.34%6.73M-20.01%9.05M100.14%37.35M-11.75%8.12M148.12%9.36M212.72%8.56M
Research and development costs 9.48%13.03M-42.43%49.59M-61.12%11.61M-22.84%14.69M-33.66%11.39M-40.71%11.9M68.70%86.13M313.15%29.85M142.50%19.03M435.73%17.17M
Operating profit 73.25%-5.61M33.43%-82.2M53.21%-17.77M10.70%-25.35M29.56%-18.12M33.24%-20.95M-77.12%-123.48M-131.18%-37.97M-144.32%-28.39M-333.02%-25.73M
Net non-operating interest income expense -7.35%1.55M139.87%6.63M-14.85%1.59M137.41%1.71M909.76%1.66M18,488.89%1.67M11,917.39%2.76M26,642.86%1.87M11,883.33%719K2,633.33%164K
Non-operating interest income -7.35%1.55M139.87%6.63M-14.85%1.59M137.41%1.71M909.76%1.66M18,488.89%1.67M11,917.39%2.76M26,642.86%1.87M11,883.33%719K2,633.33%164K
Other net income (expense) 2,002.63%799K1.78M576K598K564K38K
Other non- operating income (expenses) 2,002.63%799K--1.78M--576K--598K--564K--38K----------------
Income before tax 83.08%-3.26M38.87%-73.79M56.80%-15.6M16.71%-23.05M37.79%-15.9M38.68%-19.24M-58.89%-120.72M-114.52%-36.1M-95.23%-27.67M-213.80%-25.56M
Income tax
Net income 83.08%-3.26M38.87%-73.79M56.80%-15.6M16.71%-23.05M37.79%-15.9M38.68%-19.24M-58.89%-120.72M-114.52%-36.1M-95.23%-27.67M-213.80%-25.56M
Net income continuous Operations 83.08%-3.26M38.87%-73.79M56.80%-15.6M16.71%-23.05M37.79%-15.9M38.68%-19.24M-58.89%-120.72M-114.52%-36.1M-95.23%-27.67M-213.80%-25.56M
Minority interest income
Net income attributable to the parent company 83.08%-3.26M38.87%-73.79M56.80%-15.6M16.71%-23.05M37.79%-15.9M38.68%-19.24M-58.89%-120.72M-114.52%-36.1M-95.23%-27.67M-213.80%-25.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 83.08%-3.26M38.87%-73.79M56.80%-15.6M16.71%-23.05M37.79%-15.9M38.68%-19.24M-58.89%-120.72M-114.52%-36.1M-95.23%-27.67M-213.80%-25.56M
Basic earnings per share 88.89%-0.0649.32%-1.8568.27%-0.3334.12%-0.5648.10%-0.4144.33%-0.5459.22%-3.65-99.13%-1.04-90.29%-0.85-207.76%-0.79
Diluted earnings per share 88.89%-0.0649.32%-1.8568.27%-0.3334.12%-0.5648.10%-0.4144.33%-0.5459.22%-3.65-99.13%-1.04-90.29%-0.85-207.76%-0.79
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg